Fibrillogenic amylin evokes the apoptosis of human mesangial cells

Ai Peng1, Zhi-Hong Liu, Hong Zhou

  • 1Division of Nephrology, Shanghai Tenth People's Hospital of Tongji University, Shanghai, China.

Abstract

Insights

Fibrillogenic amylin induces apoptosis in human mesangial cells (MCs). This finding may explain mesangial damage and glomerulosclerosis in diabetic nephropathy.

Area of Science:

  • Nephrology
  • Cell Biology
  • Diabetic Complications

Background:

  • Diabetic nephropathy is characterized by mesangial cell damage and glomerulosclerosis.
  • The role of amylin in this process is not fully understood.

Purpose of the Study:

  • To investigate the apoptotic effects of amylin on human mesangial cells (MCs).

Main Methods:

  • Human MCs were cultured and treated with amylin.
  • Apoptosis was assessed using transmission electron microscopy (TEM), TUNEL assay, DNA fragmentation, and flow cytometry.
  • Amylin fibrils were visualized using negative staining TEM.

Main Results:

  • Amylin induced characteristic apoptotic changes in MCs, including chromatin condensation and apoptotic bodies.
  • TUNEL staining, DNA fragmentation, and flow cytometry confirmed amylin-induced apoptosis in a dose-dependent manner.
  • Amylin nano-scale fibrils were observed, and no significant lactate dehydrogenase release occurred.

Conclusions:

  • Fibrillogenic amylin triggers apoptosis in human MCs in vitro.
  • This mechanism may contribute to hypocellular mesangial damage and glomerulosclerosis in diabetic nephropathy.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.